John Patrick Shannon Jr., See Remarks at Xeris Biopharma Holdings, Inc. (XERS), bought 61,538 shares at $1.64 ($101K) on 2023-11-17, disclosed to the SEC on 2023-11-17.
Open-market purchase of $101k XERS by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.64 | 30,769 | $50K | 50.0% |
| 2 | $1.64 | 30,769 | $50K | 50.0% |
| Total | $1.64 avg | 61,538 | $101K | 100% |
| Filing → |
| XERS | BUY | 2021-11-12 | $210K | — | Filing → |
| XERS | BUY | 2020-05-14 | $78K | — | Filing → |
| XERS | BUY | 2020-05-11 | $25K | — | Filing → |